The $200K Challenge is an annual start-up competition hosted by M2D2 focused on identifying and rewarding disruptive companies in the medical technology and biotechnology industries.
Every year we receive scores of entries from entrepreneurs worldwide. This year, up to 20 finalists will become eligible to win a share of our $200,000purse of sponsor-provided, in-kind services. These services include lab and office space; engineering, product development, legal, regulatory, clinical, and business services. Past winners have been empowered to bring their innovations to life—and to market.
We welcome innovations that address the full range of medical device challenges, and this year we're especially interested in ideas that can benefit from our association with the BARDA DRIVe initiative.
Key Challenge dates—Mark your Calendar!
- Tuesday, January 8th: Application Opens
- Tuesday, January 15th: Live Webinar: "All About the $200K Challenge." Watch the archive.
- Thursday, January 18th: $25 app fee ends; regular fee of $50 begins
- Wednesday, January 30th: Info session & Venture Capital Financing Event
- Monday, February 18: Entries close
- Wednesday, March 6th: Finalists Announced
- Wednesday, March 13th: Finalists materials due
- Wed. March 13th-Tues. 26th: Coaching sessions for finalists
- Wednesday, March 27th: Finalist Pitch Competition
- Wednesday, April 10th: Awards Ceremony, Winners Announced
The Massachusetts Medical Device Development Center (M2D2) is a lifeline for the state’s smaller medical device companies, offering inventors and executives easy, affordable, and coordinated access to world-class researchers and resources at the Lowell and Worcester campuses of the University of Massachusetts.
M2D2 leverages the engineering, business and clinical strengths of the UMass campuses in Lowell and Worcester to provide fee-based services in the areas of business planning, product prototype development and clinical pathway assistance.
M2D2 is proud to be the only BARDA DRIVe accelerator in New England. BARDA’s DRIVe aims to empower people and give them a greater role in their health outcomes. They are actively seeking better ways to detect threats, point-of-use indicators, biological and physiological sensing technologies.
Thanks to a recent $7.9 million grant from the National Institutes of Health (NIH), M2D2 is also currently playing a large role in the development of CAPCaT, a new Center for Advancing Point-of-Care Technologies focused on heart, lung, blood and sleep disorders.